During the show, our booth hosted numerous one-on-one consultations and successive business meetings; many brief initial inquiries extended into in-depth technical discussions over 30 minutes. Global clinical-focused research teams maintained strong interest in our CAR-T monitoring solutions, and we advanced multiple potential cooperation projects with US medical centers.
We surveyed visiting researchers about their core hurdles in ongoing CAR-T projects, collecting consistent industry feedback:
- Solid tumor-targeted CAR-T development ranks as the top industry challenge;
- Therapy toxicity, product safety and long-term cell persistence are widely shared pain points;
- Production workflow and CAR detection difficulties are also commonly discussed concerns.
Beyond technical exchanges, the team enjoyed diversified off-show activities including academic poster review, partner dinner gatherings and a charity 5K running race around San Diego’s coastal harbor.
